Elecon Engineering reports Q1FY26 standalone net profit of ₹5,857 lakh

Elecon Engineering Company Ltd reported a standalone net profit of ₹5,857 lakh for the quarter ended June 30, 2026, compared to ₹23,892 lakh in the corresponding period of the previous year. Total income from operations for the quarter stood at ₹39,824 lakh, down from ₹41,008 lakh in the same quarter last year. The company’s basic earnings per share (EPS) for the quarter was ₹2.61, compared to ₹10.65 in the prior year.

Financial Performance

The unaudited financial results for the quarter were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 10, 2026. The Statutory Auditors have expressed an unmodified conclusion on these standalone and consolidated financial results.

Particulars	Standalone Q1FY26 (₹ in Lakhs)	Standalone Q1FY25 (₹ in Lakhs)
Total Income from Operations	39,824	41,008
Net Profit for the period after tax	5,857	23,892
Basic Earnings Per Share (₹)	2.61	10.65

Consolidated Results

On a consolidated basis, the company reported a net profit of ₹7,035 lakh for the quarter ended June 30, 2026, compared to ₹12,665 lakh in the same period of the previous year. Total income from operations for the consolidated entity was ₹52,056 lakh for the quarter, against ₹49,057 lakh in the corresponding quarter of the previous year. The basic EPS for the consolidated results stood at ₹3.14 for Q1FY26, compared to ₹7.82 in Q1FY25.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-2.01%	-10.88%	-18.55%	+17.81%	-25.08%	+557.51%

Elecon Engineering Company has published the Notice of Postal Ballot in newspapers on July 1, 2026, seeking shareholder approval for the re-appointment of Mr. Pranav C. Amin as a Non-Executive & Independent Director for a second term of five years. The resolution requires approval through a special resolution via remote e-voting. Mr. Amin, who holds a DIN of 00245099, currently serves as the Managing Director of Alembic Pharmaceuticals Limited.

The Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved his appointment as an Additional Director effective June 22, 2026, subject to shareholder approval. He has submitted a declaration confirming he meets the criteria for independence under Section 149(6) of the Companies Act, 2013, and Regulation 16(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Postal Ballot Schedule

The company has engaged Link Intime India Private Limited to facilitate the e-voting process. The cut-off date for determining eligibility is June 26, 2026. Shareholders holding shares in either dematerialized or physical form as of this date are entitled to vote.

Event	Date and Time
Cut-off date	Friday, June 26, 2026
Dispatch of Postal Ballot Notice	Tuesday, June 30, 2026
E-voting start date	Thursday, July 2, 2026 (9:00 a.m. IST)
E-voting end date	Friday, July 31, 2026 (5:00 p.m. IST)
Declaration of results	Within 2 working days from conclusion of e-voting

Director Profile and Remuneration

Mr. Pranav C. Amin holds a degree in Economics/Industrial Management from Carnegie Mellon University and an MBA in International Management from Thunderbird School of Global Management. His expertise lies in management and leadership, with over two decades of experience in the pharmaceutical sector.

During the financial year 2025-26, Mr. Amin drew sitting fees of ₹ 2.22 Lakhs and a commission of ₹ 17.50 Lakhs, aggregating to ₹ 19.72 Lakhs. He attended all 5 Board Meetings held during FY 2025-26 and 1 Board Meeting held up to the completion of his first tenure in 2026. He does not hold any shares in the company.

The Scrutinizer for the postal ballot process is Mr. S. Samdani (FCS: 3677), Partner of M/s. Samdani Shah and Kabra. The results will be announced within two working days of the conclusion of the e-voting period and will be available on the company's website and the stock exchanges.